Story perspectives
Oprah Calls Ozempic a 'Gift,' Sparking Market Surge
1/16/2026
34 6
1 of 1
Story summary
- Oprah Winfrey described Ozempic as a "gift," boosting Novo Nordisk's market value beyond Norway's GDP.
- Ozempic is a synthetic GLP-1 hormone linked to a scientific journey marked by rivalry and discovery, with Svetlana Mojsov's research pivotal.
- Donnellan's book tells the story of Sarah, a marketing executive, whose career improved after Ozempic weight loss.
- Donnellan notes potential side effects and raises questions about the drug's implications for free will and addiction treatment.
